Ultra-hypofractionated radiotherapy with focal boost for high-risk localized prostate cancer (HYPO-RT-PC-boost): in silico evaluation with histological reference
The histologically confirmed tumor was only partially boosted. Regions with more aggressive disease received better coverage. These findings provide a rational for prioritizing OARs in treatment planning.
Authors
- Kristina Sandgren (ORCID: https://orcid.org/0000-0001-8890-241X)
- Camilla Thellenberg‐Karlsson (ORCID: https://orcid.org/0000-0002-7061-7255)
- Joakim Jonsson (ORCID: https://orcid.org/0009-0001-0567-0666)
- Lars Olsson (ORCID: https://orcid.org/0000-0001-6090-6697)
- Adalsteinn Gunnlaugsson (ORCID: https://orcid.org/0000-0003-1354-8537)
- Tufve Nyholm (ORCID: https://orcid.org/0000-0002-8971-9788)
- Björn Zackrisson (ORCID: https://orcid.org/0000-0002-5219-4682)
- Anders R. J. Bergh (ORCID: https://orcid.org/0000-0001-5163-5821)
- Katrine Riklund (ORCID: https://orcid.org/0000-0001-5227-8117)
- Karin Söderkvist (ORCID: https://orcid.org/0000-0002-3683-3763)
- Jan Axelsson (ORCID: https://orcid.org/0000-0002-3731-3612)
- Sara Strandberg
- Josefine Grefve (ORCID: https://orcid.org/0000-0002-3488-7784)
- Erik Nilsson (ORCID: https://orcid.org/0000-0001-8747-4759)
- Mathieu Moreau (ORCID: https://orcid.org/0009-0008-7213-9198)
- A. Nilsson (ORCID: https://orcid.org/0009-0003-8430-4166)
- A. Keeratijarut Lindberg (ORCID: https://orcid.org/0000-0002-1612-6957)
Institutions
- Lund University (SE)
- Skåne University Hospital (SE)
- Umeå University (SE)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-10-27
- DOI
- https://doi.org/10.2340/1651-226x.2025.44211
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancerfonden
- Vetenskapsrådet